The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma

Insights into the biology of advanced renal cell carcinoma (aRCC) and the development of agents targeting the vascular endothelial growth factor (VEGF) pathway have positively impacted the outcomes for patients with aRCC. With the recent approval of the dual immune checkpoint inhibitors (ICIs), nivo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Asim Amin, Hans Hammers
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019-01-01
coleção:Frontiers in Immunology
Assuntos:
combination immunotherapy
VEGF inhibition
immune check point inhibitor
advanced renal cell carcinoma
immuno modulation
Acesso em linha:https://www.frontiersin.org/article/10.3389/fimmu.2018.03120/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados